Etoposide is a chemotherapy drug that mediates mesenchymal–epithelial transition (MET) to reduce nuclear β-catenin and the resultant downregulation of PD-L1 on tumor cells [81] (Fig. 5). The gene discussed is CD274; the disease is neoplasm.